Immunization With BCG Vaccine to Prevent Tuberculosis Infection

Stopped The sponsor has elected to discontinue/terminate the study prematurely due to slower-than-anticipated recruitment and limited remaining research funding.

Conditions

• Tuberculosis Infection

Interventions

• BIOLOGICAL: BCG (Tokyo 172) vaccine
• DRUG: Placebo

Sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicine

Collaborators

• [object Object]
• [object Object]